In patients with gout, ULORIC helps control the underlying cause—high uric acid levels. By lowering uric acid levels, ULORIC helps patients manage their gout. Keeping uric acid at a healthy level (less than 6 mg/dL) is the long-term goal for managing gout and can reduce future gout attacks over time.
ULORIC is a prescription medicine used to lower blood uric acid levels in adults with gout. ULORIC is not for the treatment of high uric acid without a history of gout.
Individual results may vary.
Do not take ULORIC if you are taking Azathioprine or Mercaptopurine.
Your gout may flare up when you start taking ULORIC; do not stop taking your ULORIC even if you have a flare. Your healthcare provider may give you other medicines to help prevent your gout flares.
A small number of heart attacks, strokes, and heart-related deaths were seen in clinical studies. It is not certain that ULORIC caused these events.
Tell your healthcare professional about liver or kidney problems or a history of heart disease or stroke.
Your healthcare professional may do blood tests to check your liver function while you are taking ULORIC.
The most common side effects of ULORIC are liver problems, nausea, gout flares, joint pain, and rash.
Please see the complete Prescribing Information and talk to your healthcare professional.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
ULORIC is a trademark of Teijin Pharma Limited registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.©2013 Takeda Pharmaceuticals U.S.A., Inc.
This site is intended for use by US residents only. 51401 03/13